(Q55479826)

12 July 2018

title

Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2. (English)

1 reference

12 July 2018

author name string

U Herrlinger

1

1 reference

12 July 2018

R Buchholz

2

1 reference

12 July 2018

P Jachimczak

3

1 reference

12 July 2018

M Schabet

4

1 reference

12 July 2018

publication date

1 March 1996

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

27

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

193-203

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/bf00165475

exact match

0 references

cites work

Meningeal carcinomatosis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00165475

Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma

21 January 2018

1 reference

12 December 2020

Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats

1 reference

12 December 2020

Clearance of macromolecular and particulate substances from the cerebrospinal fluid system of the rat

1 reference

12 December 2020

Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2.

1 reference

12 December 2020

Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor

1 reference

12 December 2020

Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 recept

1 reference

12 December 2020

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

12 December 2020

Meningeal carcinomatosis: development of an experimental model

1 reference

12 December 2020

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

1 reference

12 December 2020

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

1 reference

12 December 2020

Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2.

1 reference

12 December 2020

Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model

1 reference

12 December 2020

Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients

1 reference

12 December 2020

Effects of γ-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy

1 reference

12 December 2020

Protein A, avidin, and biotin in immunohistochemistry

1 reference

12 December 2020

Tolerance and cerebrospinal fluid pharmacokinetics of intrathecally administered human natural interleukin-2: a phase I trial

1 reference

12 December 2020

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

12 December 2020

Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy

1 reference

12 December 2020

Diagnosis and therapy of meningosis neoplastica

1 reference

12 December 2020

Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration

1 reference

12 December 2020

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

12 December 2020

Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukin-2.

1 reference

12 December 2020

Modulation of T-cell function by gliomas

1 reference

12 December 2020

Adoptive immunotherapy of intracerebral metastases in mice

1 reference

12 December 2020

Modulation of transforming growth factor-beta 1 effects by cytokines

1 reference

12 December 2020

Leptomeningeal metastases--treatment results in 98 consecutive patients

1 reference

12 December 2020

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

12 December 2020

Leptomeningeal cancer in leukemia and solid tumors

1 reference

12 December 2020

Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Generation of cytotoxic immune responses during the progression of a rat glioma.

1 reference

12 December 2020

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

12 December 2020

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

1 reference

12 December 2020

Cytokines and immunoregulatory molecules in malignant glial neoplasms

1 reference

12 December 2020

Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells

1 reference

12 December 2020

Primary Bioassay of Human Tumor Stem Cells

1 reference

12 December 2020

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Current concepts in leptomeningeal metastasis

1 reference

12 December 2020

Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia

1 reference

12 December 2020

Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer

1 reference

12 December 2020

Recent advances in immunobiology of brain tumors

1 reference

12 December 2020

Biology of the human malignant lymphomasIII. Intracranial heterotransplantation in the nude, athymic mouse

1 reference

12 December 2020

Intrathecal administration of interleukin-2 for meningeal carcinomatosis due to malignant melanoma: sequential evaluation of intracranial pressure, cerebrospinal fluid cytology, and cytokine induction

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00165475

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018